Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics source : Nutriband.com save search
Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
Published: 2023-01-24 (Crawled : 11:00) - nutriband.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.27%
H: 0.1%
C: 0.1%
NTRB | $4.18 -2.11% -3.39% 24K
|
Manufacturing
|
| O: -2.85%
H: 0.0%
C: -1.76%
RANI | $6.11 -22.17% -28.48% 580K
|
|
| O: -1.1%
H: 1.91%
C: -3.82%
MRK | $125.23 -0.11% 0.0% 6M
|
Health Technology
|
| O: 0.11%
H: 0.0%
C: -1.35%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: -0.86%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
conference transdermal
Nutriband Inc to Participate at the RHK Capital Disruptive Growth Conference on December 5-6, 2022
Published: 2022-12-02 (Crawled : 13:20) - nutriband.com
NTRB | $4.18 -2.11% -3.39% 24K
|
Manufacturing
|
| O: -0.26%
H: 2.31%
C: 1.8%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -1.63%
H: 6.61%
C: 4.13%
conference growth
Nutriband Receives Notice of Issuance from the Canadian Intellectual Property Office for its AVERSA™ Abuse Deterrent Transdermal Technology Patent
Published: 2022-12-01 (Crawled : 12:00) - nutriband.com
NTRB | $4.18 -2.11% -3.39% 24K
|
Manufacturing
|
| O: -1.02%
H: 5.93%
C: 0.52%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -0.77%
H: 2.33%
C: -4.65%
patent transdermal technology
Nutriband Supports Newly Published CDC Opioid Prescribing Guidelines
Published: 2022-11-08 (Crawled : 12:00) - nutriband.com
NTRB | $4.18 -2.11% -3.39% 24K
|
Manufacturing
|
| O: -6.56%
H: 6.78%
C: -0.73%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: 1.38%
H: 2.72%
C: 0.0%
guidelines opioid
Nutriband Inc. to Manufacture Fleur Marché-branded Wellness Patches Under Exclusive Agreement
Published: 2022-10-27 (Crawled : 11:00) - nutriband.com
NTRB | $4.18 -2.11% -3.39% 24K
|
Manufacturing
|
| O: 8.17%
H: 0.0%
C: -1.33%
JWN | News | $18.74 4.4% 0.75% 6M
|
Retail Trade
|
| O: 1.25%
H: 1.66%
C: -2.27%
URBN | $37.01 -0.16% -0.16% 1.1M
|
Retail Trade
|
| O: 0.94%
H: 1.54%
C: -0.2%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: 1.26%
H: 0.62%
C: -4.97%
BBBY | $0.0751 -27.09% -47.14% 190M
|
Retail Trade
|
| O: 5.95%
H: 5.14%
C: -3.49%
agreement
Nutriband Subsidiary, 4P Therapeutics LLC, Conducts Phase 1b Clinical Study for Sorrento Therapeutics, Inc. on Lymphatic Etanercept Delivery in Rheumatoid Arthritis Patients With Results To Be Presented at the 2022 American College of Rheumatology Conference
Published: 2022-10-26 (Crawled : 12:00) - nutriband.com
NTRB | $4.18 -2.11% -3.39% 24K
|
Manufacturing
|
| O: 0.24%
H: 10.71%
C: -0.95%
SRNE | $0.028 -8.85% 42K
|
Health Technology
|
| O: -3.14%
H: 10.39%
C: 3.25%
conference therapeutics study phase 2b
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.